Full-Time

Executive Medical Affairs Director

Psychiatry

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$294.1k - $425.9kAnnually

+ Bonus + Equity Incentive Program

Expert

San Diego, CA, USA

Must reside locally; this is an office-based role.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • MD required and 8+ years of relevant experience
  • Preferred experience: Clinical Practice experience in Psychiatry
  • Highly effective communicator and collaborator, both internally and externally
  • Passion for education and addressing unmet medical needs in psychiatry
  • Expert in Psychiatry with prior leadership in pharma
  • Recognized as a subject matter expert and thought leader in psychiatry with extensive medical and business experience within a strategic organization
  • Requires broad and comprehensive expertise in leading-edge theories and techniques within strategic job function
  • Applies ingenuity and creativity to problem analysis and resolution in complicated and/or novel situations
  • Influences internal/external business and/or industry issues
  • Excellent leadership skills, mentors lower levels, and/or leads indirect teams
  • Exceptional interpersonal, communications, problem solving, analytical thinking, influencing skills
  • Sets longer-term vision for department or priority projects
  • Ability to meet multiple deadlines across a variety of projects/programs, with a high degree of accuracy and efficiency
  • Ability to apply advanced analytical thought and judgment
  • Proactive, innovative, with excellent problem-solving/decision making skills
  • Ability to work in a cross functional team and matrix environment
Responsibilities
  • Collect and synthesize insights from external stakeholders to understand education and data needs of providers, payers, patients, and caregivers to inform Medical Affairs strategic planning
  • Drive cross-functional alignment on medical affairs strategy, brand planning, and clinical development and data generation programs
  • Develop and execute medical strategies for Ingrezza and the broader psychiatry portfolio that aligns with business goals and market needs including oversight of tactical planning for field medical teams
  • Collaborate with cross-functional teams to generate real-world evidence, clinical data, and health economic research for products
  • Oversee Field Medical (e.g., MSL, CPL) strategy and performance for Ingrezza and priority pipeline assets including supporting strategic disease education and engagement planning
  • Advance the science related to company products and clinical development programs by growing relationships with Key Opinion Leaders (KOLs) and partnering with research organizations
  • Develop robust training initiatives to ensure the highest level of scientific technical acumen for all Medical Affairs team members
  • Partner with the Health Economics and Outcomes Research (HEOR) function in the creation and execution of research
  • Assess protocol grant submissions to the Investigator-Initiated Trial (IIT) program
  • Assist the Medical Communications function in creating and implementing publications and data dissemination plans, including medical congress tactics
  • Oversee the development and delivery of tailored medical programs and activities (e.g., presentations, publications, Advisory Boards) to support evidence-based decision-making among customers
  • Provide monthly status updates and team performance reports to the VP of Medical Affairs & HEOR on key initiatives
  • Ensure all Medical Affairs strategies, tactics, and initiatives are in compliance with regulations, guidelines, and ethical standards
  • Perform other duties as assigned, contributing to the overall success of Medical Affairs initiatives
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 2 data for NBI-1117568 in schizophrenia and the launch of INGREZZA SPRINKLE highlight Neurocrine's innovative pipeline and commitment to addressing unmet medical needs.
  • The FDA's acceptance of crinecerfont's New Drug Applications with Priority Review could lead to a significant market breakthrough if approved.
  • Recent investments and executive appointments suggest strong confidence in the company's future growth and strategic direction.

What critics are saying

  • The pharmaceutical industry is highly competitive, and Neurocrine must continuously innovate to maintain its market position.
  • Regulatory hurdles, such as FDA rejections, could delay product launches and impact financial performance.

What makes Neurocrine Biosciences unique

  • Neurocrine Biosciences is pioneering in the treatment of congenital adrenal hyperplasia (CAH) with crinecerfont, a first-in-class therapy that hasn't seen innovation in 70 years.
  • The company offers unique formulations like INGREZZA SPRINKLE, addressing specific patient needs such as dysphagia, which sets them apart in the pharmaceutical landscape.
  • Their focus on rare and serious endocrine disorders, combined with successful clinical trials, positions them as a leader in niche therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?